GRM Overseas: ₹1,769 Cr Revenue, 5% Margins—the Rice Export Machine That Can’t Quite Raise Its Baton
General information and entertainment, not investment advice. The author is not a SEBI-registered adviser or research analyst. No recommendation, no promised returns. Markets carry risk including loss of capital. Figures may not be current. Consult a registered adviser before acting.
Growth came roaring back. FY26 revenue hit ₹1,769 Cr, up 31% from ₹1,346 Cr in FY25—a sharp rebound from FY24’s slide. Net profit climbed to ₹74.34 Cr, marking a 22.6% climb.
But margins stayed flat. Operating profit margin: 5.1% in FY26, unchanged from FY25. PAT margin inched from 4.5% to 4.2%—a small compression, not a widening. The stock has tanked 39.6% in the past three months, and earlier this month, the exchange sought a clarification on the price movement. No undisclosed event was found. The company then surprised with a 2:1 bonus in December 2025 and a warrant conversion in February 2026.
The tension: revenue scales, but profitability doesn’t. Domestic sales are now 41% of the mix (up from 23% in FY24), yet margin lift isn’t visible. Is this a transition play or a stall?
2. Introduction
GRM Overseas was incorporated in 1995 as an offshoot of the Garg family’s rice milling legacy, which traces back to 1974 as Garg Rice & General Mills. The company sits on a production capacity of roughly 440,800 MT per annum (Panipat, Haryana) and another 110,000 MT through Naultha and Gandhidham, with 9 sortex plants holding an additional 1,400 MT per day cleaning capacity.
The core export game has been rice to the Middle East and Europe—40+ countries, 200+ international distributors. Retail tie-ups include ASDA Walmart (UK), Carrefour (UAE), Tesco (UK), and a roster of regional players. Domestically, after years of playing small, the 10X brand (launched through subsidiary GRM Foodkraft Pvt Ltd) is now a material driver—spices, atta, ready-to-eat biryani kits, and the newly added mustard oil under 10X Shakti (launched July 2024).
In August 2024, management announced 10X Ventures: a ₹200 Cr digital-first rollup play targeting D2C brands and lifestyle categories, aiming to turn the rice business into a “blended house of brands” with traditional FMCG discipline and e-commerce agility. The company also expanded its Diplomat Georgia tie-up to place Tanoush basmati rice into Eastern European distribution. Promoter holding has slipped from 72% in mid-2025 to 62.5% after warrant conversions and bonus dilution, while FIIs have crept in to 9.5%.
3. Business Model: WTF Do They Even Do?
The playbook is old, the execution uneven.
Exports (59% of FY26 revenue, ₹1,044 Cr). Basmati rice—premium grades like Himalaya River (blue, jumbo, sella, brown) and Tanoush (organic, 1121 emperor, 1401 king)—goes in bulk to foreign retailers and distributors. The company buys paddy seasonal, mills, sorts, packages, and ships. Volumes recovered: Q4 FY26 showed ₹597 Cr sales, a 105% leap from Q4 FY25 (₹291 Cr). That kind of swing is either real or inventory release; the data doesn’t scream manipulation, but caution is apt.
Domestic Retail (41% of FY26, ₹725 Cr). The 10X brand—”essential consumer goods, kitchen necessities”—is now the second leg. Rice, spices, atta, ready-to-eat and instant offerings. 103,545 kirana touchpoints tracked in the system (as of last published). Flipkart, BigBasket, Meesho, Amazon, Zomato for modern trade; JioMart, Udaan, Elasticurn for general trade. A mustard oil launch in July 2024 suggests category creep—margin expansion, or just broader SKU clutter?
The risk. Exports are weather-dependent (paddy yields), FX-exposed (revenues in dollars, costs partly in rupees), and hostage to global demand shifts. The recent domestic push into branded retail is a margin play but requires scale and advertising—capital-heavy, slow to compound. Management is hedging with 10X Ventures, but that’s a separate venture whose returns are years out.
Capacity utilization remains opaque. With 550 MT/day milling and 1,400 MT/day sorting, the group can theoretically handle 2+ lakh MT annually; FY26 sales of ₹1,769 Cr likely represent 1.3–1.5 lakh MT at blended prices (~₹1,200/MT), so the mills are running, not idling.
4. Financials Overview
Figures are consolidated, in ₹ crore.
Metric
FY26
FY25
YoY Change
FY24
YoY Change
Revenue
1,769
1,347
+31.4%
1,312
+2.6%
EBITDA
127
107
+18.7%
100
+6.5%
PAT
74.3
60.6
+22.6%
59.8
+1.3%
EPS (Annualised FY)
3.59
3.37
+6.5%
3.32
+1.5%
Key Movements:
Q4 FY26 (Jan-Mar 2026) on its own: Revenue ₹597 Cr (up 105% QoQ from Q3’s ₹362 Cr), net profit ₹21.61 Cr (EPS ₹1.04 annualised = 4 × Q4 × (1/4) of year… no, wait—Q4 is the final quarter of the fiscal year. Full FY EPS is ₹3.59, so use that as the reported EPS). Operating profit margin in Q4: 5.0% (₹30 Cr ÷ ₹597 Cr). PAT margin: 3.6%.
The surge in Q4 is the headline. Months of tepid volumes (Q2: ₹327 Cr, Q3: ₹362 Cr) suddenly compressed into a final-quarter export dash. Whether this is real demand realization or year-end inventory shifting isn’t clear from the numbers alone. The credit rating agency noted “improvement in the scale of operations in 9MFY2025 post a marginal decline in FY2024.”
5. Market Expectations & Historical Multiples
This section describes how the market is currently pricing the company and how that compares with its own history and peer group. It is descriptive, not predictive.
Metric
Current
Historical Avg (5 Yr)
Peer Median
P/E
26.1x
25.5x
16.6x
EV/EBITDA
17.6x
—
—
ROE
14.5%
21.3%
14.5%
ROCE
14.0%
—
14.2%
P/B
3.21x
—
2.18x
The market currently pays 26.1x earnings here versus a peer median of 16.6x. The multiple sits above the company’s own 5-year average of 25.5x, suggesting current sentiment is in line with historical peaks, not discounting.
Return on Equity stands at 14.5%—healthy against the peer set median of 14.5% but well below the company’s own 5-year average of 21.3%, signalling diminished capital efficiency. ROCE mirrors that: 14.0% now, peer median 14.2%. The business is no longer a high-return outlier.
What is the market pricing in? The domestic expansion (41% of revenue, growing) is betting on scale in 10X; the export recovery (Q4’s surge) is betting on demand normalization post global slowdown; the 10X Ventures rollup (₹200 Cr committed) is betting on FMCG roll-up economics, which have worked for others but carry operational risk. The multiple sits flat despite margin compression and ROE decline, suggesting the market is either already pessimistic or waiting for the domestic/venture thesis to crystallize.
6. What’s Cooking
Warrant conversion push. In August 2024, management issued 90.7 lakh convertible warrants at ₹150 (₹37.5 warrant price upfront). By February 2026, 77.18 lakh had converted, raising equity and diluting shares. This capital infusion—₹86.82 Cr received by February, with ₹136.05 Cr expected if all were to convert—is meant for 10X Ventures rollups. The promoter stake dropped from 72% to 62.5% in the